These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 1922929

  • 1. Monoamine oxidase inhibitors prevent striatal neuronal necrosis induced by transient forebrain ischemia.
    Matsui Y, Kumagae Y.
    Neurosci Lett; 1991 May 27; 126(2):175-8. PubMed ID: 1922929
    [Abstract] [Full Text] [Related]

  • 2. Effect of long-term treatment with selective monoamine oxidase A and B inhibitors on dopamine release from rat striatum in vivo.
    Lamensdorf I, Youdim MB, Finberg JP.
    J Neurochem; 1996 Oct 27; 67(4):1532-9. PubMed ID: 8858937
    [Abstract] [Full Text] [Related]

  • 3. Deamination of norepinephrine, dopamine, and serotonin by type A monoamine oxidase in discrete regions of the rat brain and inhibition by RS-8359.
    Kumagae Y, Matsui Y, Iwata N.
    Jpn J Pharmacol; 1991 Jan 27; 55(1):121-8. PubMed ID: 1904113
    [Abstract] [Full Text] [Related]

  • 4. Release of endogenous dopamine from rat isolated striatum: effect of clorgyline and (-)-deprenyl.
    Hársing LG, Vizi ES.
    Br J Pharmacol; 1984 Nov 27; 83(3):741-9. PubMed ID: 6439273
    [Abstract] [Full Text] [Related]

  • 5. Monoamine oxidase-dependent metabolism of dopamine in the striatum and substantia nigra of L-DOPA-treated monkeys.
    Di Monte DA, DeLanney LE, Irwin I, Royland JE, Chan P, Jakowec MW, Langston JW.
    Brain Res; 1996 Oct 28; 738(1):53-9. PubMed ID: 8949927
    [Abstract] [Full Text] [Related]

  • 6. L-3,4-dihydroxyphenylalanine-induced dopamine release in the striatum of intact and 6-hydroxydopamine-treated rats: differential effects of monoamine oxidase A and B inhibitors.
    Wachtel SR, Abercrombie ED.
    J Neurochem; 1994 Jul 28; 63(1):108-17. PubMed ID: 8207420
    [Abstract] [Full Text] [Related]

  • 7. Influence of monoamine oxidase inhibitors on striatonigral dynorphin system: a study with deprenyl and clorgyline.
    Sivam SP.
    Neuropeptides; 1993 Jul 28; 25(1):35-45. PubMed ID: 7692341
    [Abstract] [Full Text] [Related]

  • 8. Effects of selective monoamine oxidase inhibitors on the in vivo release and metabolism of dopamine in the rat striatum.
    Butcher SP, Fairbrother IS, Kelly JS, Arbuthnott GW.
    J Neurochem; 1990 Sep 28; 55(3):981-8. PubMed ID: 2117053
    [Abstract] [Full Text] [Related]

  • 9. Selective monoamine oxidase subtype inhibition and striatal extracellular dopamine in the guinea-pig.
    Ilani T, Lamensdorf I, Finberg JP.
    Br J Pharmacol; 2000 Aug 28; 130(8):1992-8. PubMed ID: 10952692
    [Abstract] [Full Text] [Related]

  • 10. Guinea pig striatum as a model of human dopamine deamination: the role of monoamine oxidase isozyme ratio, localization, and affinity for substrate in synaptic dopamine metabolism.
    Azzaro AJ, King J, Kotzuk J, Schoepp DD, Frost J, Schochet S.
    J Neurochem; 1985 Sep 28; 45(3):949-56. PubMed ID: 3928811
    [Abstract] [Full Text] [Related]

  • 11. Influence of selective inhibition of monoamine oxidase A or B on striatal metabolism of L-DOPA in hemiparkinsonian rats.
    Finberg JP, Wang J, Goldstein DS, Kopin IJ, Bankiewicz KS.
    J Neurochem; 1995 Sep 28; 65(3):1213-20. PubMed ID: 7643100
    [Abstract] [Full Text] [Related]

  • 12. In vivo comparison of the effects of inhibition of MAO-A versus MAO-B on striatal L-DOPA and dopamine metabolism.
    Brannan T, Prikhojan A, Martínez-Tica J, Yahr MD.
    J Neural Transm Park Dis Dement Sect; 1995 Sep 28; 10(2-3):79-89. PubMed ID: 9620056
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of monoamine oxidase-B by (-)-deprenyl potentiates neuronal responses to dopamine agonists but does not inhibit dopamine catabolism in the rat striatum.
    Paterson IA, Juorio AV, Berry MD, Zhu MY.
    J Pharmacol Exp Ther; 1991 Sep 28; 258(3):1019-26. PubMed ID: 1679846
    [Abstract] [Full Text] [Related]

  • 14. Effects of monoamine oxidase inhibitors on levels of catechols and homovanillic acid in striatum and plasma.
    Hovevey-Sion D, Kopin IJ, Stull RW, Goldstein DS.
    Neuropharmacology; 1989 Aug 28; 28(8):791-7. PubMed ID: 2506486
    [Abstract] [Full Text] [Related]

  • 15. Alteration of dopamine synthesis in rat striatum subsequent to selective type A monoamine oxidase inhibition.
    Schoepp DD, Azzaro AJ.
    J Neurochem; 1981 Aug 28; 37(2):527-30. PubMed ID: 6790675
    [Abstract] [Full Text] [Related]

  • 16. Age influences abnormalities in striatal dopamine metabolism during and after transient forebrain ischemia.
    Ding A, Németh G, Hoyer S.
    J Neural Transm Park Dis Dement Sect; 1992 Aug 28; 4(3):213-25. PubMed ID: 1627255
    [Abstract] [Full Text] [Related]

  • 17. Effect of MAO inhibitors on the uptake and metabolism of dopamine in rat and human brain.
    Tekes K, Tóthfalusi L, Gaál J, Magyar K.
    Pol J Pharmacol Pharm; 1988 Aug 28; 40(6):653-8. PubMed ID: 3152003
    [Abstract] [Full Text] [Related]

  • 18. Role of type A and B monoamine oxidase on the formation of 3,4-dihydroxyphenylacetic acid (DOPAC) in tissues from the brain of the rat.
    Garrett MC, Soares-da-Silva P.
    Neuropharmacology; 1990 Oct 28; 29(10):875-9. PubMed ID: 2123970
    [Abstract] [Full Text] [Related]

  • 19. Brain dialysis: in vivo metabolism of dopamine and serotonin by monoamine oxidase A but not B in the striatum of unrestrained rats.
    Kato T, Dong B, Ishii K, Kinemuchi H.
    J Neurochem; 1986 Apr 28; 46(4):1277-82. PubMed ID: 2419508
    [Abstract] [Full Text] [Related]

  • 20. Participation of type A monoamine oxidase in the activated deamination of brain monoamines shortly after reperfusion in rats.
    Kumagae Y, Matsui Y, Iwata N.
    Jpn J Pharmacol; 1990 Dec 28; 54(4):407-13. PubMed ID: 2087001
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.